Dimensional Fund Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $291M | Buy |
3,636,881
+35,997
| +1% | +$2.97M | 0.06% | 358 |
|
|
2025
Q4 | $307M | Sell |
3,600,884
-82,864
| -2% | -$6.8M | 0.06% | 334 |
|
|
2025
Q3 | $286M | Buy |
3,683,748
+305,854
| +9% | +$23.9M | 0.06% | 350 |
|
|
2025
Q2 | $264M | Buy |
3,377,894
+180,902
| +6% | +$13.5M | 0.06% | 359 |
|
|
2025
Q1 | $232M | Buy |
3,196,992
+201,784
| +7% | +$14.4M | 0.06% | 391 |
|
|
2024
Q4 | $222M | Buy |
2,995,208
+653,577
| +28% | +$45.7M | 0.05% | 425 |
|
|
2024
Q3 | $155M | Buy |
2,341,631
+942,302
| +67% | +$68.5M | 0.04% | 674 |
|
|
2024
Q2 | $129M | Buy |
1,399,329
+219,486
| +19% | +$19.4M | 0.03% | 744 |
|
|
2024
Q1 | $113M | Buy |
1,179,843
+7,007
| +0.6% | +$589K | 0.03% | 854 |
|
|
2023
Q4 | $89.4M | Buy |
1,172,836
+58,442
| +5% | +$4.07M | 0.03% | 996 |
|
|
2023
Q3 | $77.2M | Buy |
1,114,394
+2,501
| +0.2% | +$201K | 0.03% | 1013 |
|
|
2023
Q2 | $105M | Buy |
1,111,893
+11,368
| +1% | +$988K | 0.03% | 798 |
|
|
2023
Q1 | $91M | Buy |
1,100,525
+10,864
| +1% | +$854K | 0.03% | 886 |
|
|
2022
Q4 | $81.3K | Sell |
1,089,661
-14,775
| -1% | -$1.14M | 0.02% | 934 |
|
|
2022
Q3 | $91.3M | Buy |
1,104,436
+140
| +0% | +$13.5K | 0.04% | 767 |
|
|
2022
Q2 | $105M | Sell |
1,104,296
-7,149
| -0.6% | -$740K | 0.04% | 690 |
|
|
2022
Q1 | $131M | Sell |
1,111,445
-13,243
| -1% | -$1.49M | 0.04% | 633 |
|
|
2021
Q4 | $146M | Sell |
1,124,688
-23,142
| -2% | -$2.7M | 0.04% | 579 |
|
|
2021
Q3 | $130M | Buy |
1,147,830
+9,645
| +0.8% | +$1.1M | 0.04% | 617 |
|
|
2021
Q2 | $118M | Sell |
1,138,185
-2,867
| -0.3% | -$270K | 0.04% | 707 |
|
|
2021
Q1 | $95.4M | Sell |
1,141,052
-6,203
| -0.5% | -$524K | 0.03% | 873 |
|
|
2020
Q4 | $105M | Sell |
1,147,255
-69,224
| -6% | -$5.74M | 0.04% | 700 |
|
|
2020
Q3 | $97.1M | Sell |
1,216,479
-52,419
| -4% | -$4.09M | 0.04% | 597 |
|
|
2020
Q2 | $87.7M | Buy |
1,268,898
+43,326
| +4% | +$3.08M | 0.04% | 675 |
|
|
2020
Q1 | $77.1M | Buy |
1,225,572
+79,644
| +7% | +$5.74M | 0.04% | 614 |
|
|
2019
Q4 | $89.1M | Sell |
1,145,928
-29,232
| -2% | -$2.28M | 0.03% | 823 |
|
|
2019
Q3 | $86.1M | Sell |
1,175,160
-426,786
| -27% | -$30M | 0.03% | 810 |
|
|
2019
Q2 | $98.7M | Sell |
1,601,946
-72,027
| -4% | -$4.36M | 0.04% | 694 |
|
|
2019
Q1 | $107M | Sell |
1,673,973
-129,477
| -7% | -$7.39M | 0.04% | 608 |
|
|
2018
Q4 | $92.1M | Buy |
1,803,450
+67,062
| +4% | +$3.39M | 0.04% | 607 |
|
|
2018
Q3 | $101M | Sell |
1,736,388
-37,362
| -2% | -$1.83M | 0.04% | 702 |
|
|
2018
Q2 | $86.1M | Sell |
1,773,750
-519
| -0% | -$24.2K | 0.03% | 796 |
|
|
2018
Q1 | $82.5M | Sell |
1,774,269
-21,945
| -1% | -$953K | 0.03% | 782 |
|
|
2017
Q4 | $67.5M | Buy |
1,796,214
+15,675
| +0.9% | +$575K | 0.03% | 990 |
|
|
2017
Q3 | $64.9M | Buy |
1,780,539
+4,980
| +0.3% | +$190K | 0.03% | 991 |
|
|
2017
Q2 | $70M | Buy |
1,775,559
+12,042
| +0.7% | +$440K | 0.03% | 838 |
|
|
2017
Q1 | $55.3M | Sell |
1,763,517
-8,832
| -0.5% | -$277K | 0.03% | 1073 |
|
|
2016
Q4 | $55.4M | Sell |
1,772,349
-67,749
| -4% | -$2.2M | 0.03% | 1023 |
|
|
2016
Q3 | $73.9M | Buy |
1,840,098
+22,275
| +1% | +$839K | 0.04% | 649 |
|
|
2016
Q2 | $60.4M | Sell |
1,817,823
-1,581
| -0.1% | -$54.1K | 0.03% | 772 |
|
|
2016
Q1 | $53.5M | Buy |
1,819,404
+4,944
| +0.3% | +$136K | 0.03% | 846 |
|
|
2015
Q4 | $47.8M | Buy |
1,814,460
+54,240
| +3% | +$1.41M | 0.03% | 893 |
|
|
2015
Q3 | $41.7M | Sell |
1,760,220
-56,298
| -3% | -$1.36M | 0.03% | 972 |
|
|
2015
Q2 | $43.1M | Buy |
1,816,518
+311,994
| +21% | +$7.04M | 0.03% | 1020 |
|
|
2015
Q1 | $35.7M | Buy |
1,504,524
+278,664
| +23% | +$6.25M | 0.02% | 1194 |
|
|
2014
Q4 | $26M | Buy |
1,225,860
+172,026
| +16% | +$3.46M | 0.02% | 1465 |
|
|
2014
Q3 | $17.9M | Buy |
1,053,834
+88,452
| +9% | +$1.4M | 0.01% | 1746 |
|
|
2014
Q2 | $13.8M | Buy |
965,382
+11,334
| +1% | +$154K | 0.01% | 1987 |
|
|
2014
Q1 | $11.8M | Buy |
954,048
+18,108
| +2% | +$209K | 0.01% | 2049 |
|
|
2013
Q4 | $10.3M | Sell |
935,940
-8,832
| -0.9% | -$99.6K | 0.01% | 2146 |
|
|
2013
Q3 | $11M | Buy |
944,772
+22,920
| +2% | +$268K | 0.01% | 2031 |
|
|
2013
Q2 | $10.3M | Buy |
+921,852
| New | +$10.9M | 0.01% | 1962 |
|
Other funds holding EW
VCM
VPM
Dimensional Fund Advisors's EW Position: Q1 2026 in Review
Dimensional Fund Advisors increased its Edwards Lifesciences (EW) stake by 1% in Q1 2026, buying an estimated $2.97M and bringing the position to 3,636,881 shares worth $291M. The position accounts for 0.06% of the portfolio, ranked #358.
Dimensional Fund Advisors first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $307M in Q4 2025. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Dimensional Fund Advisors held 3,636,881 shares of Edwards Lifesciences worth $291M as of Q1 2026.
- Dimensional Fund Advisors bought 35,997 Edwards Lifesciences shares in Q1 2026, an estimated $2.97M.
- Edwards Lifesciences made up 0.06% of Dimensional Fund Advisors's portfolio in Q1 2026, its #358 holding.
- Dimensional Fund Advisors first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- Dimensional Fund Advisors's Edwards Lifesciences position peaked at $307M in Q4 2025.
- 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.